#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal muscular atrophy Eosinophilic oesophagitis Lymphangiosarcoma Hypochondroplasia Alpha-1 antitrypsin deficiency Polymyositis Corneal neovascularisation Eosinophilic granulomatosis with polyangiitis Toxic epidermal necrolysis Bone marrow disorder Adrenogenital syndrome Neoplasm malignant Uterine leiomyosarcoma Hairy cell leukaemia Pulmonary hypertension More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma – Life with Disease Shprintzen-Goldberg syndrome – Trials in Disease Haemophilia B without inhibitors – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Basic Information Pituitary-dependent Cushing’s syndrome – Basic Information Activated PI3 kinase delta syndrome Langerhans’ cell histiocytosis – Trials in Disease Bronchiolitis obliterans syndrome – Life with Disease Castleman’s disease Glomerulonephritis rapidly progressive – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VTX2735 SODIUM Ecoo16 Infigratinib Piromelatine Specific Nucleic Acid Sna-Ebv Levothyroxine Vemurafenib SAT-3247 OXALATE Pemetrexed Disodium Mitazalimab Resmetirom Dexamethasone Acetate Ph. Eur. Alglucosidase Alfa Fianlimab Cd7-Cart01 Dornase Alfa Lacutamab Valsartan Imsidolimab Specific Nucleic Acid Sna-Xfsc More therapies…

    Learn about Your Condition

    Oesophageal food impaction Spinal cord injury Obsessive-compulsive disorder Psoriatic arthropathy Post-acute COVID-19 syndrome Substance use disorder Becker's muscular dystrophy Stress cardiomyopathy Raynaud's phenomenon Systemic infection Thymic carcinoma Underweight Haemorrhoids Brain neoplasm Naevus flammeus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myeloid leukaemia

  • Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Autologous Cord Blood-Derived Dendritic Cells Loaded With Wt1 Peptide Pool
    The Netherlands

  • Study on the Safety and Effects of AB8939 and Azacitidine for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • 1-{4-[2-(5-Ethoxymethyl-2-Methyl-Phenylamino)-Oxazol-5-Yl]-Phenyl}-Imidazolidin-2-One
    • Azacitidine
    • Venetoclax
    France Germany Greece Spain

  • Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ep0042
    • Azacitidine
    • Venetoclax
    The Netherlands

  • Study of venetoclax and mercaptopurine combination treatment for patients with relapsed or treatment-resistant acute myeloid leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Mercaptopurine
    • Venetoclax
    Belgium

  • Study of Dasatinib for Patients with Acute Myeloid Leukemia Not Responding to Venetoclax-Azacitidine Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Dasatinib
    France

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Gemtuzumab Ozogamicin
    • Mitoxantrone Hydrochloride
    Austria Czechia Germany Greece Italy Poland
Previous Page
1 … 9 10 11 12 13 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!